Upcoming Events

10.09.2024, 09:00-13.09.2024, 18:00

From Target to Market - The GLA Biotech & Pharma Summer School

The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.

The trainer team consists of experts in medicine, pharmaceutical industry, biotech companies, contract research and consulting organizations etc.

Since the course modules illustrate the drug development step by step, during the lectures and workshops attendees will become familiar with the complete process and will learn what the pharma industry and authorities are like.

Due to the compact, complete and competent course in a familiar atmosphere you will be able to
- apply the lecture contents during interactive and case-related exercises within small learning groups coached by the trainers
- get a deep insight into the process of drug development and build up contacts to industry experts
- discuss your questions with the trainers  

Course Language: English

Documentation: Attendees receive comprehensive paper documentationat the beginning of the course. The binders include print-outs of all presentation slides and working sheets as used during the workshop sessions. All paper documents, links to further information and literature will also be made available electronically through a course sharepoint.

Size: The course is limited to a maximum of 16 participants and will only take place with a minimum of 6 participants. Due to organizational reasons, early registration is recommended.

Target Audience: The course is directed to natural scientists, PhD students and postdocs of natural scientific and medical degree programs who work in fundamental research, biotechnology or in research pharma companies with little or no experience in drug development.

Learning Goals: After course completion, attendees will have a basic understanding of the entire drug development process in the pharmaceutical industry and in biotechnology. Thus, based on their individual background, they should be able to identify potential occupational fields in the industry and authorities dealing with drug development and drug approvals.

Certification: The participation of the course will be certified by the German Life Science Association VBIO “Verband Biologie, Biowissenschaften und Biomedizin” and the Gläsernes Labor Akademie (GLA).

Course fees: 1.850,00 € per participant plus VAT, course binders and catering according to to program as attached. Participants of academical institutions pay 1.480,00 € plus 19% VAT. Assosciations which are members of the VBIO as well as  private applicants will get a fee reduction of 10%.

Further information 
Dr. Uwe Lohmeier, Head GLA

u.lohmeier@campusberlinbuch.de

Version 07 Nov 2023
Subject to modifications

Location:

Campus Berlin-Buch

From Target to Market - The GLA Biotech & Pharma Summer School

19.09.2024, 17:00-19.09.2024, 19:30

Should I Stay or Should I Go? Development Strategies for Life Science Start-Ups

Insights from ThermoFisherScientific Experts and Partners with acquisition - a Panel Discussion

Continue to grow independently or merge with a larger company? In the highly competitive life science industry start-up companies often face during their development this important strategic decision. The panel will feature renowned speakers who are international experts and collaborators with ThermoFisherScientific (TFS) in the field of Biotechnology and Life Science. They share their personal stories and experiences, providing valuable insights for the audience.

With

• Roland Geyer, Innovation Partnerships Team TFS, Basel, Switzerland,
• Hanno Hermann, AppLyo Jena GmbH,
• Christina Quensel, German Association of Innovation, Technology and Business Incubation Centres (BVIZ), Campus Berlin-Buch GmbH,
• Axel Trefzer, CEO TFS GENEART GmbH, Germany,
• Uwe Lohmeier, Head of Gläsernes Labor Akademie (GLA), Moderation.

The panelists will address the following topics:

• Factors essential to a successful “exit” in the industry,
• Potential challenges and opportunities under a new management,
• Cooperation models,
• Key factors to consider when evaluating potential partnerships or collaborations for start-ups.

This is another opportunity to engage in a stimulating discussion and exchange ideas with both other attendees and our esteemed experts. The talk will be followed by a networking event where you can socialize over snacks and drinks.

Don't miss out on this valuable event!

Further topics planned for fall / winter 2024 / 2025 

•  Venture Capital in Biotechnology
• International cooperation and founding programs in Life Sciences
•  Team 4.0 - Networked working in biotechnology
• Life Science Marketing: A potential way of scientist to promote their products
  CROs in diagnostics and therapeutics development
• …

About "Talk in the Cube" 
With the event series "Talk in the Cube", we bring business and science together on the Berlin-Buch campus and connect founders of start-ups or life science companies with scientists, e.g. from the Max Delbrück Center, FMP, Charité and BIH. We invite experts on business topics or trends in the life sciences and highlight aspects such as

• What innovations are there in the start-ups and who is driving them forward?
•  How does the life science business world work and where can synergies with science be created?
• How does the "networked laboratory" work and how do you live "sustainability in the laboratory"?

Target audience:
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions. 

Costs:
Participation is free of charge. Registration is requested. 

Where:
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin 

Further information: 
Uwe Lohmeier per E-Mail: u.lohmeier@campusberlinbuch.de 

Quelle :Gläsernes Labor Akademie
Registration is requested

Location:

BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin 

Registration is requested.